Psychiatry and Neurology, Epilepsy · Detroit, MI
NPI
1073781571
Since 2008
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
4201 Saint Antoine St, Suite 8a & 8b
Detroit, MI, 48201
Phone (313) 745-4275
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
271 services
Medicare patients, 2024
152
Average age 68
Drug cost, 2024
$557K
1,247 prescriptions
Company payments, 2025
$282
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maysaa M Basha was code 95720 (neurologic), 50 times for 26 patients. In total Maysaa M Basha billed 271 services in 25 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 50 | 26 | $160.91 | $8,045 |
| 95819 Neurologic | Facility | 46 | 44 | $39.12 | $1,800 |
| 99214 Office E&M - Established | Facility | 34 | 24 | $65.98 | $2,243 |
| 99232 Hospital E&M - Subsequent | Facility | 21 | 16 | $60.85 | $1,278 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $95.15 | $1,522 |
| 95718 Neurologic | Facility | 12 | 12 | $94.77 | $1,137 |
By year: 2022 $21K for 290 services; 2023 $19K for 237 services; 2024 $22K for 271 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maysaa M Basha prescribed most often to Medicare patients was Lacosamide, with 200 prescriptions and refills. In total Maysaa M Basha wrote 1,247 Medicare prescriptions that cost $557K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 200 | 240 | 31 | $17K |
| Clobazam Generic | 138 | 158 | 17 | $8,373 |
| Levetiracetam Generic | 104 | 193 | 26 | $2,905 |
| Briviact Brivaracetam | 63 | 63 | Under 11 | $86K |
| Fycompa Perampanel | 48 | 48 | Under 11 | $57K |
| Lamotrigine Generic | 43 | 74 | Under 11 | $1,457 |
| Oxcarbazepine Generic | 43 | 67 | Under 11 | $2,267 |
| Clonazepam Generic | 42 | 48 | Under 11 | $912 |
| Oxtellar Xr Oxcarbazepine | 42 | 54 | Under 11 | $76K |
| Lamotrigine Er Lamotrigine | 40 | 64 | Under 11 | $16K |
| Topiramate Generic | 37 | 89 | 11 | $569 |
| Divalproex Sodium Generic | 36 | 46 | Under 11 | $547 |
| Phenobarbital Generic | 31 | 31 | Under 11 | $315 |
| Carbamazepine Er Carbamazepine | 28 | 34 | Under 11 | $3,487 |
| Divalproex Sodium Er Divalproex Sodium | 26 | 48 | Under 11 | $781 |
Brand drugs: 286 claims; generic drugs: 930 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maysaa M Basha $282 ($282 in general payments such as food, travel and fees) from 5 companies. The largest payer was SK Life Science, Inc. with $95.45.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.